In this episode, we delve into the legitimacy of DHS Ventures amidst the allure of fast profits. Exploring the concept of Patient Capital, we contrast speculative trends with a focus on sustainable growth highlighted by their impressive 26% median EBITDA increase. Hear insights from Executive Vice Chairman Fernando Aguirre on the importance of long-term investments and strong financial stewardship. Join us as we conclude that in the landscape of 2025, Patient Capital stands as the cornerstone of building enduring success.